U.S. Case Shiller home price index rose 0.06% in December to 173.02 U.S. Case Shiller home price index rose 0.06% in December to 173.02, versus 172.92 in November (revised down from 172.94) for the 20-City composite, beating forecasts of a small decline. This breaks a string of 3 straight monthly declines. Compared to last year, home prices accelerated to a 4.46% y/y gain versus the 4.29% y/y pace previously. The 10-City composite edged up 0.07% to 187.81 compared to November's 187.68 (revised from 187.71). That's up 4.30% y/y compared to 4.15% y/y. All 20 cities surveyed posted annual gains, led by San Francisco (9.35% y/y), Miami (8.4% y/y) and Denver (8.14% y/y).
FDA Pharmacy Compounding Advisory Committee to hold a meeting The Committee discusses proposed criteria for developing the list of bulk drug substances that may be used to compound drug products in accordance with section 503A of the FD&C Act and also discusses six substances nominated for inclusion on the list on Day 2 of the meeting being held at FDA Silver Spring, MD's offices on February 24 at 8:15 am. Webcast Link
FDA to hold a joint advisory committee meeting The Dermatologic & Ophthalmic Drugs Advisory Committee and Ophthalmic Devices Panel discuss Avedro's New Drug Application (NDA) 203324 for Riboflavin Ophthalmic Solutions with UV-A irradiation which are used in corneal collagen cross-linking and proposed to be indicated for treatment of progressive keratoconus or corneal ectasia following refractive surgery in a joint committee meeting being held in FDA Silver Spring, Maryland's offices on February 24 at 8 am. Webcast Link